Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Record gives bullish outlook after solid third quarter

(Sharecast News) - Record's share price jumped on Friday after the specialist currency and asset manager said full-year revenues would be ahead of market forecasts following a solid third quarter. The company said it generated an additional £1.3m in performance fees during the three months to 31 December due to greater currency volatility during the period. This brings performance fees for the first three quarters combined to £2.9m.

Assets under management fell to $100.5bn by the period-end, down from $106bn three months earlier, with net flows broadly unchanged and FX movements having a $4.9bn adverse impact.

The FX change was driven by the strengthening of the US dollar against the Swiss franc - the currency in which the majority of Record's AUM is denominated.

"With management fee expectations for the full year unchanged and with £2.9m of performance fees recognised for the nine months ending 31 December 2024, we now expect revenue to be slightly ahead of previous expectations," said chief executive Jan Witte.

The stock was up nearly 9% at 51.62p by 0857 GMT.

Share this article

Related Sharecast Articles

Chesnara's £260m purchase of HSBC Life UK clears regulatory hurdle
(Sharecast News) - Life and pension consolidator Chesnara has received regulatory approval for its £260m acquisition of HSBC's UK life insurance manufacturing business.
GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Orosur nears completion of Pepas drilling
(Sharecast News) - Orosur Mining said drilling at its Pepas gold prospect in Colombia was nearing completion as the company moves toward an initial NI43-101 compliant mineral resource estimate, while first drill holes at its El Pantano project in Argentina have confirmed the presence of a previously undrilled mineral system.
Botswana Diamonds reports progress in 'difficult year' for industry
(Sharecast News) - Botswana Diamonds reported progress across its exploration portfolio for the year ended 30 June despite what it described as a "very difficult year for the diamond industry", as the AIM-listed company diversified into critical minerals and expanded the use of artificial intelligence in its exploration strategy.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.